These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 17118837

  • 1. Endocrine ophthalmopathy and radioiodine therapy.
    Karlsson FA.
    Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
    [Abstract] [Full Text] [Related]

  • 2. Graves' ophthalmopathy and 131I therapy.
    Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A.
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [Abstract] [Full Text] [Related]

  • 3. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
    Salvatore D, Fenzi G.
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
    Dietlein M, Dederichs B, Weigand A, Schicha H.
    Exp Clin Endocrinol Diabetes; 1999 Apr; 107 Suppl 5():S190-4. PubMed ID: 10614920
    [Abstract] [Full Text] [Related]

  • 6. [Current understanding of pathogenesis of Graves ophthalmopathy].
    Ando T, Eguchi K.
    Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
    [Abstract] [Full Text] [Related]

  • 7. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
    Dunkelmann S, Rudolph F, Prillwitz A, Groth P, Schümichen C.
    Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
    [Abstract] [Full Text] [Related]

  • 8. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA, Zang S, Kahaly GJ.
    Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
    [Abstract] [Full Text] [Related]

  • 9. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A.
    Thyroid; 1992 Jul; 2(2):171-8. PubMed ID: 1525588
    [Abstract] [Full Text] [Related]

  • 10. Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre.
    Tahrani AA, Rangan S, Moulik P.
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):471-3. PubMed ID: 17647147
    [Abstract] [Full Text] [Related]

  • 11. Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis.
    Vannucchi G, Campi I, Covelli D, Dazzi D, Currò N, Simonetta S, Ratiglia R, Beck-Peccoz P, Salvi M.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3381-6. PubMed ID: 19567525
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.
    Barth A, Probst P, Bürgi H.
    J Endocrinol Invest; 1991 Mar; 14(3):209-12. PubMed ID: 2071823
    [Abstract] [Full Text] [Related]

  • 15. Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
    Vannucchi G, Covelli D, Campi I, Currò N, Dazzi D, Rodari M, Pepe G, Chiti A, Guastella C, Lazzaroni E, Salvi M.
    Thyroid; 2019 Dec; 29(12):1828-1833. PubMed ID: 31860407
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe.
    Rosetti S, Tanda ML, Veronesi G, Masiello E, Premoli P, Gallo D, Cusini C, Donati S, Sabatino J, Ippolito S, Piantanida E, Bartalena L.
    J Endocrinol Invest; 2020 Mar; 43(3):381-383. PubMed ID: 31587179
    [No Abstract] [Full Text] [Related]

  • 18. Post-radioiodine De Novo Onset Graves' Ophthalmopathy: Case Reports and a Review of the Literature.
    Batra R, Krishnasamy SK, Buch H, Sandramouli S.
    Semin Ophthalmol; 2015 May; 30(3):227-31. PubMed ID: 24409943
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.